Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more inclusive treatment.

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

The Huntington disease Digital Motor Score, derived from smartphone sensor-based motor tests, can improve detection of disease progression.

Mindfulness and transcranial direct current stimulation offer therapeutic benefit for reducing situational urgency urinary incontinence symptoms in women.

For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief.